Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · December 14, 2023

Bosutinib in Pediatric Patients With Chronic-Phase CML Resistant or Intolerant to at Least One Previous TKI

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921
J. Clin. Oncol 2023 Nov 30;[EPub Ahead of Print], E Brivio, E Pennesi, ME Willemse, ADR Huitema, Y Jiang, HDR van Tinteren, VHJ van der Velden, BH Beverloo, ML den Boer, LAJ Rammeloo, C Hudson, N Heerema, K Kowalski, H Zhao, L Kuttschreuter, FJ Bautista Sirvent, A Bukowinski, C Rizzari, J Pollard, L Murillo-Sanjuán, M Kutny, S Zarnegar-Lumley, M Redell, S Cooper, Y Bertrand, A Petit, J Krystal, M Metzler, D Lancaster, JP Bourquin, J Motwani, IM van der Sluis, F Locatelli, ME Roth, N Hijiya, CM Zwaan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading